The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
Its worth discussing upfront
What published clinical research shows: The STEP-1 trial (semaglutide, published in NEJM 2021) demonstrated that participants with obesity or overweight without diabetes who received semaglutide 2.4 mg weekly plus lifestyle intervention experienced mean weight loss of 14.9% over 68 weeks
Before adding ashwagandha to your semaglutide regimen, consult your healthcare provider
For those who are visual learners, our team and collaborators often break down complex topics and procedures on channels like the MorelliFit YouTube channel, which can be a fantastic supplementary resource
Because it produces inconsistent results that appear to be biological variability when they're actually handling artifacts